Clinical trial
The Role of Stroma-Derived Soluble TßRIII in Neuroblastoma
NCT01553448 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Stroma-Derived Soluble TßRIII in Neuroblastoma
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- Not reported
- Enrollment
- 75 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
neoplastic syndrome, neuroblastoma